Senior insider sale
FATE THERAPEUTICS INC — senior position signals high conviction
$38.9K
38.43K shares
What this filing means
MENDLEIN JOHN plans to sell 38.43K shares of FATE THERAPEUTICS INC valued at approximately $38.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007928
38.43K
Shares to sell
$38.9K
Approx. market value
38.43K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
6/6/2023
8.65KStock Option Exercise
Cash
1/19/2023
28.46KRestricted Stock Vesting
Compensation
6/2/2022
1.32KTotal acquired38.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/6/2023 | Restricted Stock Vesting Compensation | 8.65K | — |
1/19/2023 | Stock Option Exercise Cash | 28.46K | — |
6/2/2022 | Restricted Stock Vesting Compensation | 1.32K | — |
| Total | 38.43K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
38.43K
Market value
$38.9K
12/24/2025
Total
Units
38.43K
Value
$38.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/24/2025 | 38.43K | $38.9K | NASDAQ | Planned |
| Total | 38.43K | $38.9K | ||